Clinical Trials Browser

Phase 1/2 × Carcinoma, Hepatocellular × toripalimab × Clear all

NCT03867370 2023-11-29

Toripalimab in Combination With Lenvatinib as Neoadjuvant Therapy in Resectable Hepatocellular Carcinoma

Phase 1/2 Terminated

Gastrointestinal

Carcinoma, Hepatocellular

NCT03864211 2022-09-29

Thermal Ablation Followed by Immunotherapy for HCC

Phase 1/2 Unknown

Gastrointestinal

Carcinoma, Hepatocellular

NCT04926532 2021-06-15

Toripalimab

Phase 1/2 Unknown

Gastrointestinal

Carcinoma, Hepatocellular